[ENDP] Endo International plc


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 16.27 Change: 0.5 (3.17%)
Ext. hours: 16.25 Change: -0.02 (-0.12%)

chart ENDP

Refresh chart

Strongest Trends Summary For ENDP

ENDP is in the medium-term down -64% below S&P in 7 months. In the long-term down -96% below S&P in 8 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women?s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men?s and women?s health, and prostate health. The company?s products also inc

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y-1.55% Sales Growth - 4 Quarters -15.23% Sales Growth - Q/Q-10.73% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-2.55% ROE-8.7% ROI-3.62%
Current Ratio1.55 Quick Ratio1.37 Long Term Debt/Equity2.86 Debt Ratio0.83
Gross Margin49.62% Operating Margin-27.98% Net Profit Margin-11.54% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities996.86 M Cash From Operating Activities-930.48 M Gross Profit329.86 M
Net Profit-89.81 M Operating Profit45.75 M Total Assets14.15 B Total Current Assets5.33 B
Total Current Liabilities3.44 B Total Debt5.39 B Total Liabilities10.01 B Total Revenue714.13 M
Technical Data
High 52 week18.3 Low 52 week5.62 Last close6.52 Last change-1.21%
RSI32.56 Average true range0.51 Beta0.74 Volume2.59 M
Simple moving average 20 days-12.43% Simple moving average 50 days-17.18% Simple moving average 200 days-44.67%
Performance Data
Performance Week-19.11% Performance Month-8.81% Performance Quart-38.32% Performance Half-51.78%
Performance Year4.32% Performance Year-to-date-10.68% Volatility daily5.27% Volatility weekly11.79%
Volatility monthly24.16% Volatility yearly83.68% Relative Volume179.67% Average Volume3.55 M
New High New Low


2019-09-16 15:14:19 | OxyContin maker Purdue Pharma files for bankruptcy

2019-09-16 09:33:00 | Mallinckrodt and Other Opioid Stocks Are Falling After Purdue Pharma Announced Its Bankruptcy

2019-09-11 16:06:23 | Francis Chou's Chou Europe Fund Semi-Annual 2019 Commentary

2019-09-11 12:13:04 | Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up

2019-09-10 16:21:49 | Francis Chou's Chou Associates Fund Semi-Annual 2019 Letter

2019-09-10 04:56:08 | Endo Files BLA for CCH With the FDA for Cellulite Candidate Revised

2019-09-09 17:28:09 | Mallinckrodt MNK to Resolve Opioid Cases with Ohio Counties

2019-09-09 09:50:01 | Endo International Files BLA for Label Expansion of Xiaflex

2019-09-06 16:31:00 | Why DocuSign, Endo International, and Guidewire Software Jumped Today

2019-09-06 11:55:38 | Opioid Crisis Fallout Earns Short-Sellers an $880 Million Payday

2019-09-06 11:52:57 | Why Endo International Stock Is Soaring Today

2019-09-06 10:07:00 | Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum CCH in Patients with Cellulite

2019-09-06 08:08:12 | Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation

2019-09-06 08:00:49 | Opioid Crisis Squeezes Last Air Out of a Stock Bubble

2019-09-05 16:49:45 | Endo agrees to pay $10M to settle Ohio opioid lawsuits

2019-09-05 12:00:00 | Why Endo International Shares Are Tanking Today

2019-09-05 11:52:00 | Endo Announces Execution of Final Settlement Agreement and Release Resolving _Track 1_ Opioid Cases

2019-09-05 10:35:02 | Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease

2019-09-05 00:36:25 | Edited Transcript of ENDP earnings conference call or presentation 6-Aug-19 11:30am GMT

2019-09-04 09:30:01 | Endo ENDP Up 5.8% Since Last Earnings Report: Can It Continue?

2019-09-04 07:30:00 | Endo Announces Approval of First Generic Orfadin® in U.S.

2019-09-03 06:30:00 | Endo Launches Authorized Generic Version of Noxafil® posaconazole Delayed-release Tablets in the United States

2019-09-02 09:41:01 | Allergan Settles Ahead of Multi-District Opioid Litigation

2019-08-30 08:00:12 | Will Opioid Litigation Take its Toll on Pharma Companies?

2019-08-28 08:35:38 | Endo International plc NASDAQ:ENDP Insiders Have Been Selling

2019-08-27 11:14:16 | J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read

2019-08-27 11:01:03 | J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case

2019-08-27 10:40:02 | Case-Shiller Index Nudges Up

2019-08-27 07:36:44 | Will Johnson & Johnson Become the Next Teva?

2019-08-23 10:15:02 | J&J's JNJ Opioid Lawsuit Verdict in Oklahoma Due Next Week

2019-08-23 06:38:25 | Hall of Fame quarterback huddles with Endo to raise awareness for little-known hand disorder

2019-08-22 10:35:00 | Football Legend John Elway Reveals He has Dupuytren's Contracture and Wants Others to Get the _Facts on Hand_

2019-08-22 07:42:11 | Mallinckrodt MNK Stock Down 70.8% YTD on Numerous Lawsuits

2019-08-21 16:15:54 | Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms?

2019-08-21 13:38:05 | Endo Up on Settlement of a Few Cases Related to Opioid Drugs

2019-08-21 10:42:02 | Are Options Traders Betting on a Big Move in Endo ENDP Stock?

2019-08-20 16:30:00 | Why Baidu, Endo International, and Hilton Grand Vacations Jumped Today

2019-08-20 12:20:08 | Endo, Allergan could avoid trial with opioid settlements

2019-08-20 11:54:00 | Why Endo International Shares Are Soaring Again Today

2019-08-20 10:20:42 | UPDATE 2-Drugmakers Endo, Allergan agree to $15 mln in settlements in major opioid case

2019-08-20 10:15:11 | Endo, Allergan could avoid trial with Ohio over opioid crisis

2019-08-20 10:12:00 | Endo's stock soars after settlement agreement on track 1 opioid cases

2019-08-20 09:28:00 | Endo Announces Settlement in Principle to Resolve _Track 1_ Opioid Cases

2019-08-20 06:43:00 | Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit

2019-08-20 03:23:00 | [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

2019-08-19 16:36:00 | Why Mallinckrodt and Endo International Shares Jumped Today

2019-08-13 10:05:02 | Is Endo International ENDP A Great Pick for Value Investors?

2019-08-09 10:17:02 | BioDelivery BDSI Earnings & Sales Beat Estimates in Q2

2019-08-07 11:15:03 | Endo ENDP Q2 Earnings & Revenues Beat Estimates, Down Y/Y

2019-08-06 20:24:29 | Endo International ENDP Q2 2019 Earnings Call Transcript